Trial Profile

VPRIV Non-Interventional Study in Patients Previously Treated With Other Enzyme Replacement Therapies (ERTs)/Substrate Reduction Therapies (SRTs)

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Velaglucerase alfa (Primary)
Indications Gaucher's disease type I
Focus Adverse reactions
Sponsors Shire

Most Recent Events

25 Jan 2022 Status changed from recruiting to discontinued. Reason the study was stopped: The decision was taken after careful consideration relating to recruitment challenges that could impact the scientific value of the study.
10 Aug 2021 Planned End Date changed from 31 May 2021 to 31 May 2023.
10 Aug 2021 Planned primary completion date changed from 31 May 2021 to 31 May 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com